arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 5/2014 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Second SGLT2 inhibitor for type 2 diabetes mellitus: canagliflozin (INVOKANA)

    THERAPY FROM A CRITICAL VIEWPOINT

    Withdrawal of approval: alternatives for metoclopramide drops (PASPERTIN, generics)

    a-t READER'S QUESTIONS AND COMMENTS

    Are there new data on ranolazine (RANEXA) for angina pectoris?

    STADA-Diagnostik-DNA-Statine-Test: Does the gene test improve treatment with statins?

    IN BRIEF

    Stored neuraminidase inhibitors - an expensive "multi-system failure"

    Quality review: olanzapine (ZYPREXA, generics) 10 mg tablets

    Mammography: recommendation against screening programms in Switzerland
    free

    Medical apps may carry risks, but recalls are still rare

    SIDE EFFECTS

    Thrombotic microangiopathy with interferon beta (e.g. REBIF)

    Administration error: do not inject the rotavirus vaccine ROTARIX

    e a-t IN INTERNET

    Advertising questioned: ESBERITOX COMPACT against common cold

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles